This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!, Inc. And Cegedim, Inc. Form Strategic Alliance To Provide Instant Cash Rebates On Consumer Goods And Services And Pharmaceutical Products Nationwide

Stocks in this article: GPCM

"Everyone loves cash rebates with no strings attached – especially our members – part of the 120 million-strong age 50+ market of grandparents, boomers and seniors that control 75% of the nation's wealth. Best of all, the rebates may be used to buy anything, anywhere -- like any other debit card," said Steve Leber, Chairman and Co-CEO of "The enormous amount of what's known as 'breakage' in the rebate card business is a problem we aim to address on behalf of our members. No more filling out rebate cards and waiting six weeks to get your rebate, if it ever shows up."

Joseph Bernstein, Co-CEO added, "As the marketing partner in the venture, intends to make the Grand Card a staple that everyone will want to carry each time they visit a pharmacy or participating retailer. After all, who does not want free cash? And, the Grand Card is not limited to seniors. Everyone will be able to get it to obtain rebates on electronics, travel, car rentals, sports clubs, jewelry, and so many more other offerings we will have. This will be a great cross-marketing venue: Every affinity issuer will be able to market its products and services to customers of every other affinity card issuer, creating a huge national network of benefits for all cardholders."

About Cegedim and OPUS Health

Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,200 people in more than 80 countries and generated revenue of over $1 billion in 2011. Cegedim SA is listed in Paris (EURONEXT: CGM).  OPUS Health, a division of Cegedim Relationship Management, is the premier loyalty marketing company with over a decade of experience helping pharmaceutical companies implement HCP trial as well as patient acquisition and adherence solutions. OPUS designs, manages, and measures co-pay, voucher, debit card, cash discount, buy-and-bill, and adherence programs. OPUS process all pharmacy claims with a proprietary in-house claims adjudication system that enables customized solutions in ways other suppliers cannot. Core strengths of OPUS Health are its program design and execution, ownership of technology and pharmacy relationships, multi-disciplined account management and cloud-based reporting and detailing tools. Why have pharmaceutical companies trusted OPUS Health to provide patient savings more than 50 million times? Because it works.  Learn more at

About, Inc. (OTCBB: GPCM) is engaged with the largest and wealthiest demographic group in the U.S. – America's 70 million grandparents, who control around 50% of the nation's personal wealth.  As a social media and marketing company with almost 2 million registered members, seeks to deliver a seamless experience to its audience across all digital platforms. Starting in 2013, the company will be awarding the Recommended ® designation to providers of best in class products and services.

More than anything, celebrates what it means to be a grandparent today.  The company's mission is to give today's grandparents—who like no other grandparents in history are engaged, vibrant and ageless, ideas and opportunities to connect to what's important to them.  As The Ultimate Resource for Grandparents , seeks to strengthen the ties between family members, promote health and wellbeing, and give timely information and expert advice on what really matters to grandparents, from family, relationships, health and money, to entertainment, travel and retirement planning.

Forward-Looking Statements 

Various statements in this release, including those that express a belief, expectation or intention, may be considered "forward-looking statements" that involve risks and uncertainties that could cause actual results to differ materially from projected results. Accordingly, investors should not place undue reliance on forward-looking statements as a prediction of actual results. The forward-looking statements may include projections and estimates concerning the timing and success of specific projects. Forward-looking statements may also include projections and estimates concerning our future operating results and financial condition. When we use the words "will," "believe," "intend," "expect," "may," "should," "anticipate," "could," "estimate," "plan," "predict," "project," or their negatives, or other similar expressions, the statements which include those words are usually forward-looking statements. When we describe strategy that involves risks or uncertainties, we are making forward-looking statements. The forward-looking statements in this press release speak only as of the date of this press release; we disclaim any obligation to update these statements. We have based these forward-looking statements on our current expectations and assumptions about future events. While our management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond our control.

2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs